+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunoprophylaxis of polymicrobic cellulitis with a human monoclonal antibody against lipopolysaccharide antigen of pseudomonas aeruginosa



Immunoprophylaxis of polymicrobic cellulitis with a human monoclonal antibody against lipopolysaccharide antigen of pseudomonas aeruginosa



Abstracts of the Annual Meeting of the American Society for Microbiology 89: 137




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031823729

Download citation: RISBibTeXText


Related references

Activity of anti-lipopolysaccharide human IgM monoclonal antibodies in the treatment of Pseudomonas aeruginosa-Staphylococcus aureus polymicrobic cellulitis. Serodiagnosis and ImmunoTherapy in Infectious Disease 3(4): 225-230, 1989

Effect of human monoclonal antibody against O-antigen and core-antigen of lipopolysaccharide on gut-derived Pseudomonas aeruginosa sepsis in mice. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 66, 2003

Immunoprophylaxis of pseudomonas aeruginosa burn wound sepsis with a cross reactive human monoclonal antibody. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 126, 1988

Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa. Fems Microbiology Immunology 2(5-6): 263-268, 1990

A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide. Infection and Immunity 59(1): 1-6, 1991

The serology of pseudomonas aeruginosa analyzed by means of quantitative immuno electrophoretic methods part 1 comparison of 13 o groups of pseudomonas aeruginosa with a polyvalent pseudomonas aeruginosa antigen antibody reference system. Acta Pathologica et Microbiologica Scandinavica Section B Microbiology 83(4): 321-327, 1975

Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Infection and Immunity 69(4): 2223-2229, 2001

Pharmacodynamic properties of lipopolysaccharide lps specific monoclonal antibody mab in pseudomonas aeruginosa thigh infections in mice. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 308, 1992

Treatment with lipopolysaccharide lps reactive monoclonal antibody mab and sparfloxacin in experimental pseudomonas aeruginosa pneumonia in neutropenic mice. American Review of Respiratory Disease 143(4 Part 2): A497, 1991

Oral ciprofloxacin and a monoclonal antibody to lipopolysaccharide protect leukopenic rats from lethal infection with Pseudomonas aeruginosa. Journal of Infectious Diseases 159(6): 1073-1082, 1989

Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide. Infection and Immunity 53(3): 656-662, 1986

Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice. Microbiology and Immunology 35(12): 1131-1141, 1991

Therapeutic efficacy of human monoclonal antibody (mAb) to Pseudomonas aeruginosa alginate in prevention and treatment of P-aeruginosa eye infections. 2005

A new common polysaccharide antigen of strains of Pseudomonas aeruginosa detected with a monoclonal antibody. Journal of Infectious Diseases 152(6): 1290-1299, 1985

Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa. Journal of Infectious Diseases 152(5): 965-970, 1985